Logo of bmcmudisBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Musculoskeletal Disorders
PMC full text:

Table 4

Final multivariate post-treatment pain-prediction models and performance metricsa

Responders (N = 249/93)b Future pain intensity (N = 262/93)b
Independent variablesOR(95 % CI) P-valueβ(95 % CI) P-value
Dose (per 6 spinal manipulation visits)1.14(0.95, 1.37)0.150−0.07(−1.35, 1.21)0.910
Time (in weeks)1.08(1.02, 1.14)0.004
 Pain intensity0.64(0.51, 0.80)<0.00110.7(8.84, 12.56)<0.001
 Days with pain (last 4 weeks)0.57(0.46, 0.70)<0.001
Objective Physical Exam
 LBP: right – left lateral bending0.76(0.63, 0.92)0.005
 LBP: right lateral bending2.95(1.21, 4.69)0.001
Performance metricsc AUC(95 % CI)RMSE(95 % CI)R2 (95 % CI)
Training set0.75016.3.366
Test set0.665(0.58, 0.74)17.5(15.0, 20.1).261(7.5, 43.2)

OR Odds ratio, PC part correlation, β regression coefficient, ROM range of motion, AUC Area under the curve (receiver operating characteristic curve), RMSE root mean squared error (SD of prediction error), R 2 coefficient of determination, LBP low back pain

aVariables were selected into the regression models using forward selection among variables with p  < .05 in the univariate analysis; dose was forced into the models. Independent variables were standardized except for dose (scale unit = 6 visits) and time (scale unit = 1 week). Lower scores were favorable for pain and days with pain

bThe first number is the sample size for the model in the training set and the second number is the N for the test set

cChance performance is indicated by 0.5 for AUC. RMSE is the standard deviation of the error in prediction of future pain intensity evaluated on the 0 – 100 pain scale. R 2 is the proportion of the variance in pain intensity explained by the independent variables in the model. Confidence intervals are given for the test set only

External link. Please review our privacy policy.